The management of the Nigeria Centre for Disease Control (NCDC) says much as it is aware of recent outcomes from a UK-Government funded clinical trial for COVID-19, Nigerian government has not approved or validated treatment for COVID-19.
The centre stated this in a statement in Abuja.
The centre said:”The results support the use of Dexamethsaone as a possible treatment to reduce the risk of death among COVID-19 patients, who require oxygen or mechanical ventilation.
“Please note that the Government of Nigeria has not validated or approved any treatment for COVID-19. In addition, the use of Dexamethasone for COVID-19 treatment has not been validated by the World Health Organization (WHO).
“We are aware of the ongoing clinical trials conducted by scientists in the UK and will work with our sister agencies to evaluate this emerging data on the use of Dexamethasone.
“We will inform the general public on outcomes, following scientific review and validation.
Meanwhile, latest statistics of the dreaded virus as at Saturday indicated that Nigeria had 31,987 confirmed cases of the virus,out of which 13,103 were discharged and 724 fatalities were recorded.
Duaglobalnews reports that the pandemic virus has so far registered over 12 million cases and spread to over 200 nations in the world.
Www.Vanguard.com
www.kogistatenews.com.ng
www.thenigerianpost.com.ng
www.punchng.com
www.dailypost.ng
